OCULAR THERAPEUTIX, INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $52.0 | $63.7 | $58.4 | $51.5 | $43.5 |
| Operating income | -$270.0 | -$171.8 | -$82.4 | -$78.7 | -$78.0 |
| Net income | -$265.9 | -$193.5 | -$80.7 | -$71.0 | -$6.6 |
| Cash Flow Statement | |||||
| Free cash flow | -$216.9 | -$136.0 | -$76.3 | -$63.3 | -$66.7 |
Shares outstanding 219.6M · Free float 90.4%
Annual filing data through FY ended December 31, 2025; float as of September 28, 2026.